Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PCORI Critics Emerge As Institute Formally Releases Draft Methods Report

This article was originally published in The Gray Sheet

Executive Summary

As the Patient-Centered Outcomes Research Institute opens the public comment period for its draft methodology report, criticisms on the institute's direction are beginning to surface, including accusations that it is becoming just another AHRQ or NIH.

You may also be interested in...



PCORI-Identified Themes From Early Comment Analysis Avoid Pharma Industry Concerns

The Patient-Centered Outcomes Research Institute identifies themes from early analysis of comments received on its Methodology Committee report, but it is not clear whether these themes address concerns raised by the pharmaceutical industry.

Building Data Infrastructure For PCORI Research Should Start Now, NIH’s Collins Says

NIH Director Collins, a member of the Patient-Centered Outcomes Research Institute board of governors, offered his vision of a data infrastructure that would enable PCORI to maximize its research capabilities while minimizing costs of conducting research. At the same PCORI-sponsored workshop, Institute Executive Director Joe Selby described the main characteristics a national data infrastructure should offer.

Methods Research Dominates PCORI Pilot Projects

The Patient-Centered Outcomes Research Institute announced the awardees of pilot project research funds, with many winners emphasizing research that advances the methodology of conducting patient-centered outcomes research.

Related Content

UsernamePublicRestriction

Register

LL1121650

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel